Skip to main content
Clinical Trials/NCT05660629
NCT05660629CompletedNot Applicable

Comparison of the Effects of Exercise and Protective Approach in the Rheumatoid Hand and Joint Mobilization Applications on Pain, Functional Status and Quality of Life

Kirsehir Ahi Evran Universitesi1 site in 1 country21 target enrollmentStarted: October 30, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
21
Locations
1
Primary Endpoint
Amount of hypertrophia and effusion in wrist joints

Study Overview

Brief Summary

The goal of this randomized-controlled study is to learn about the effectiveness of the Mulligan mobilization in rheumatoid hands. The main question it aims to answer are:

-Does mulligan mobilization reduce effusion in wrist joints with rheumatoid arthritis? Participants will take Mulligan mobilization application and active ROM exercises for their hands. Researcher will compare treatments group ith sham mobilization.

Detailed Description

Rheumatoid arthritis (RA) is a systemic disease that can lead to chronic pain, bone and soft tissue damage, and disability retirement. Alleviating pain and maintaining joint range of motion in RA are important for reducing disability. Joint mobilizations are manual therapy techniques used to increase range of motion and reduce pain. The aim of this study is to investigate the effects of rheumatoid hand exercise and protective approach and joint mobilization applications on pain, functional status and quality of life.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
30 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Having been diagnosed with RAS according to ACR and EULAR criteria,
  • Being under the control of a physiatrist for at least 1 year,
  • Have not had any upper extremity surgery in the last 6 months
  • Have the cognitive capacity to understand commands,
  • Not to be involved in any other rehabilitation program or study,

Exclusion Criteria

  • Presence of soft tissue injury and chronic bone damage in the hand,
  • Presence of acute inflammation in any joint in the previous week,
  • Presence of a degenerative or non-degenerative neurological condition that causes a change in pain perception,

Outcomes

Primary Outcomes

Amount of hypertrophia and effusion in wrist joints

Time Frame: 6 weeks

Synovial fluid (area of hypertrophy and effusion, mm2: synovial fluid MCP/region)

Distance in wrist joints

Time Frame: 6 weeks

the radiographic distance (mm) between the MCP or interphalangeal bone space (joint space MCP/region)

DAS-28

Time Frame: 6 weeks

High disease activ ity \>5.1, low disease activity ≤ 3.2, remission ≤ 2.6

Joint activity

Time Frame: 6 weeks

Primary outcomes included the automated quantification (Q) of joint activity using color Doppler pixel count calculations (% hyperemia/blood flow activity score within an inflamed joint: color Q-Doppler MCP/region)

Secondary Outcomes

  • Range of Motion(6 weeks)
  • Determining the state of pain after treatment(6 weeks)
  • Grip force(6 weeks)
  • Post-treatment status of disease-related quality of life(6 weeks)
  • Physical, social, and emotional well-being in RA(6 weeks)

Investigators

Sponsor
Kirsehir Ahi Evran Universitesi
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ömer Faruk ÖZÇELEP

Lecturer

Kirsehir Ahi Evran Universitesi

Study Sites (1)

Loading locations...

Similar Trials